Acepodia to Present Data from Preclinical and Phase 1 Studies of ACE1702 at the European Society for Medical Oncology (ESMO) 2021 Virtual Congress
Preliminary results from ongoing Phase 1 study show no dose limiting toxicity was observed with ACE1702, allowing for ongoing dose...